The proposed hypothesis for this study was that seminal testosterone/estradiol levels and/or their ratios may be a good indicator for predicting normal spermatogenesis. The concentrations of estradiol and testosterone in seminal fluid were measured using competitive immunoassay techniques in specimens collected from 192 infertile patients and 103 normospermic men. Infertile patients were subdivided into three groups according to their semen analysis results and testicular biopsy: oligozoospermia, obstructive azoospermia (OA) and non-obstructive azoospermia (NOA). Results showed that seminal testosterone levels in the infertile groups were lower than that in the normospermic individuals (p<0.01), while seminal estradiol levels in the OA group were significantly higher than those in normospermic and NOA groups (p<0.01). Testosterone/estradiol ratios in the seminal plasma from the infertile groups were significantly lower than that in the normospermic group (p<0.01). However, seminal estradiol levels among normospermic and NOA groups showed no significant differences. These results suggest that the local balance between androgen and estrogen, or their ratios, may play an important role in maintaining normal spermatogenesis. Also, decreased seminal testosterone/estradiol ratio may be a good indicator for identifying the absence of sperm production in NOA patients.
INTRODUCTION
Reports dating from as early as the 1930's have indicated that the mammalian testis could synthesize estradiol (Zondek, 1934; Kelch et al., 1972; O'Donnell et al., 2001 ) A later investigation from the early 1970's demonstrated that the human testis does indeed secrete estradiol within the spermatic vein, at a mean concentration that was 50 times greater than that in the peripheral plasma (Kelch et al., 1972) .
Furthermore, supporting evidence identified estradiol as not only originating from testicular somatic cells, but also from germ cells (Aquila et al., 2002; Carreau et al., 2003) . Importantly, investigations upon the rat testis found aromatase mRNA and its activity to be higher in the germ cells than in Leydig cells, suggesting that the germ cells are an important source of estradiol (Janulis et al., 1996) . These findings led to the hypothesis that local estrogen levels might be associated with the current state of spermatogenesis, or the total number of spermatogenic cells in the testis.
In more recent decades, several studies have reported obvious declines in human sperm counts and overall quality, accompanied by an increase in male reproductive disorders. Exposure to environmental xenoestradiol has been suggested as one possible cause for these observations (Stillman, 1982; Sharpe, Skakkebaek, 1993; Rozati et al., 2002) . Animal experimentation has also demonstrated these environmental estrogenic trends. Rats descended from a great-grandfather who was exposed to high levels of endocrine disruptors during his fetal development, positively correlated with low levels of sperm production (Anway et al., 2005; Anway, Skinner, 2006; Delbes et al., 2006) . Based on these findings, some researchers have proposed a strong connection between local estradiol elevation and spermatogenic failure. Other investigations have revealed an obvious elevation of seminal estradiol in infertile men, particularly in oligozoospermic and oligoteratoasthenozoospermic patients (Bujan et al., 1993; Luboshitzky et al., 2002) .
However, a variety of causes have been suggested to contribute to oligozoospermia and azoospermia in clinics; these include tract obstruction, inflammation, and spermatogenic failure, to name a few. More recent research has been careful to take into account the fact that most previous studies did not sub-classify the patient's etiology into oligozoospermia or oligoteratoasthenozoospermia subtypes (Bujan et al., 1993; Luboshitzky et al., 2002) . Strictly speaking, these studies were not critical enough to establish a relationship between the estradiol levels in seminal specimens and spermatogenesis. Given the circumstances, certain oligozoospermia cases caused by inflammation or obstruction are not equivalent to complete spermatogenic failure.
Apart from estradiol, androgenic influence on sperm production has also spawned much research (Voglmayr et al., 1980) Unfortunately, the relationship between intra-testicular androgens and spermatogenesis remained unclear until very recently (Jarow, Zirkin, 2005) . It was demonstrated that rat intra-testicular testosterone could be reduced by 50-60% without an adverse effect on spermatogenesis; however, there remained little known regarding the amount of testicular testosterone necessary to maintain normal spermatogenesis in the human. Prior to this investigation, the knowledge of human spermatogenesis in relation to testosterone levels was very narrow. It was known that testosterone could be converted into estrogen within the lumen of the male reproductive tract (Hess, 2000) , and that human Leydig cells could express androgen receptors, estrogen receptors and aromatase. This information suggested that the local balance between estrogenic and androgenic actions may be important for maintaining spermatogenesis (O'Donnell et al., 2001 ).
This study attempts to investigate the relationship between local estradiol/testosterone levels, their balance, and the spermatogenesis state. This was accomplished by separating specimens with a more strict grouping method. If the hypothesis is confirmed, these findings may provide a valuable biological indicator for predicting the spermatogenic state.
MATERIALS AND METHODS

Population
This study was approved by the Ethics Committee of Peking University Third Hospital, China.
Written informed consents were obtained from each participant before the initiation of the investigation.
clinics. Eligibility criteria included that all participants were in good health, were not receiving hormonal treatments and showed no signs of genital infection. All azoospermic men were followed up with results from their testicular biopsy.
Semen Analysis
Semen samples were collected by masturbation after 2-5 days of sexual abstinence. Samples were allowed to liquefy at room temperature for 30-60 min and evaluated for sperm count and motility, according to WHO criteria (WHO, 1999) . Following a semen analysis, samples were centrifuged at 3000rpm for 10 min to sediment the spermatozoa. The resulting seminal plasma was immediately separated and divided into 2 aliquots, then stored at -20 o C until assayed.
According to the results of the semen analysis, patients were divided into three groups:
Normospermic, consisted of 103 healthy normospermic men, with sperm concentrations ≥20×10 6 /ml and normal sperm motility (a≥25%, or a+b≥25%); Oligozoospermic, consisted of 94 patients with severe oligozoospermia, with sperm concentrations < 0.2×10 6 /ml; Azoospermic, contained 98 patients with azoospermia, where no sperm were found in the ejaculate following centrifugation at 3000rpm for 10 min.
Hormone measurements
Seminal plasma samples were thawed at room temperature, sufficiently mixed, then separated into 200 µl aliquots to determine the concentrations of testosterone and estradiol by a competitive immunoassay, employing the Immulite analyser (Diagnostic Products Corporation, Los Angeles, CA90045, USA). The intra-and inter-assay coefficients of variation (cv) were 5.5% and 6.8% for estradiol, and 4.8% and 5.1% for testosterone, respectively. The sensitivities of the assays were 73.4 pmol ⁄ L for estradiol and 0.7 nmol ⁄ L for testosterone.
Following-up in all azoospermic patients
All azoospermic patients were subdivided into obstructive azoospermia (OA) and non-obstructive azoospermia (NOA) groups. The OA group consisted of patients with a clinical diagnosis of obstruction.
Among these, 12 were diagnosed as congenital absence of the vas deferens and seminal vesicles (CAVD).
For CAVD patients, semen analysis showed azoospermia with low seminal volume of 0.4-1 mL and low pH of 6.5. Semen fructose tests were negative. Transrectal ultrasonography demonstrated that both the seminal vesicles and the vas deferens were critically absent. As such, the OA group was further subdivided into two smaller groups: CAVD and non-CAVD groups.
Patients with incomplete spermatogenesis comprised the NOA group. Histological evidence showed maturation arrest, Sertoli cell-only syndrome (SCOS) and tubular sclerosis/atrophy in these patients (Matsumiya et al., 1994) . For NOA patients, at least four sites were randomly biopsied from each testis.
Based on the biopsy results, the NOA group was further subdivided into two groups: NOA with sperm (+) (NOA with successful sperm recovery, classified by the successful identification of at least one spermatozoon in the biopsy); and NOA without sperm (-) (NOA with failed sperm recovery, in which no spermatozoon was found in the biopsy from either side of the testis).
Statistical analysis
For this study, all statistical analyses were carried out using SPSS 10.0 for Windows; results were expressed as a mean ± SD. Statistically significant differences between mean values were evaluated using a one-way ANOVA; a Post Hoc test (LSD or Tamhane's T2) was used for multiple comparisons.
Statistically significant differences between subgroups were compared using independent sample tests.
Correlations between study parameters were made by nonparametric Spearman correlation coefficient. A p-value <0.05 was considered statistically significant for all analyses.
Receiver operating characteristic (ROC) curves were constructed to examine the predictive value of seminal hormone levels and their ratios. Sensitivity (y-axis) against [1-specificity (x-axis)] was plotted at each threshold level and the area under the curve (AUC) was computed by the nonparametric Wilcoxon testing. The AUC value represents the predictive value for successful sperm recovery before a testicular biopsy among NOA patients. A value <0.5 represents no increased chance of recovering spermatozoa following surgery.
RESULTS
Seminal Plasma Hormone Levels
The results (mean ± SD) of seminal plasma testosterone, estradiol and T/E 2 ratios are given in Table   1 . Patient's age was not significantly different among the three groups. Seminal plasma estradiol levels in the azoospermic group were significantly higher than that in normospermic men (p<0.01); however, there were no significant differences in estradiol levels between either azoospermic and oligozoospermic groups, or oligozoospermic and normospermic groups.
Seminal plasma testosterone concentrations were significantly lower in the azoospermic group as compared to normospermic (p<0.01) and oligozoospermic groups (p<0.01). All three groups demonstrated significant differences in seminal plasma T/E 2 ratio (p<0.05).
Seminal Plasma Hormone Levels in Azoospermic Patients
After following-up all azoospermic diagnoses, a total of 79 patients (23 OA and 56 NOA) had either a testicular biopsy or epididymal aspiration performed. In the NOA group, there were 13 patients with hypospermatogenesis (HS), while the other 43 men were diagnosed with maturation arrest (MA) or Sertoli-Cell only Syndrome (SCOS; absence of sperm). The NOA group had lower seminal testosterone concentrations than both the normospermic and OA groups (p<0.01) (shown in Table 2 ); all NOA patients with either MA or SCOS, also had lower testosterone levels and T/E 2 ratios (p<0.001).
In the OA group, there were 12 patients with CAVD, while other 11 men were without CAVD. The OA group demonstrated significantly higher estradiol levels and lower T/E 2 ratios (p<0.001) as compared to the normospermic and NOA groups. In addition, the CAVD group had much higher estradiol levels (691.6±117.6 pmol/L) and lower T/E 2 ratio values (0.015±0.005) than other OA and NOA patients. After CAVD patients were excluded from the OA group, seminal estradiol levels were still significantly higher in the OA group versus the NOA group (283.7±63.8 vs. 239.2±49.9, p<0.001) (shown in Table 2 and Fig.   1 ).
Predictive value of Estradiol, Testosterone and Their Ratios in Biopsy-based Diagnoses
For all NOA patients, there were significant positive correlations between biopsy diagnoses (presence or absence of sperm) and testosterone levels within the seminal plasma (Spearman r=0.407, p=0.006), as well as T/E 2 ratios (Spearman r=0.579, p=0.000). Conversely, there were no significant correlations between biopsy diagnoses and estradiol levels (Spearman r=0.056, p=0.719) ( Table 3 ).
The predictive potency of seminal estradiol, testosterone and their ratios, was tested by ROC mapping. As displayed in Fig. 2 , the area under the ROC curve for testosterone peaked at a value of 0.771 (0.577-0.966, 95% confidence interval), while the T/E 2 ratio peaked at 0.886 (0.785-0.987, 95%
confidence interval). Several threshold values of seminal testosterone levels and T/E 2 ratios were analyzed in terms of their specificity and sensitivity. predicted to have successful surgical sperm recovery, 3 patients were found without spermatozoon in their testes, setting the misdiagnosis rate at 23.08% (3/13). And for other 14 patients, due to the mismatched values (one was less than the cutoff value, and another one was more than the cutoff value.), we could not predict their testicular biopsy. Finally, it was found 7 men with spermatozoon and other 7 men without spermatozoon in their testes.
DISCUSSION
For those men included in this study, the data shown in table 1 demonstrates significantly higher seminal plasma estradiol levels as compared to normospermic men, who were also representative of previous reports (Bujan et al., 1993; Luboshitzky et al., 2002) . The current data also suggests that azoospermic patients have extraordinarily high seminal estradiol levels, which can potentially diagnose congenital absence of the vas deferens and seminal vesicles (CAVD). There are two possible reasons for the elevated seminal estradiol levels in these patients: 1) estrogen receptor expression in the whole testes is dramatically decreased in MA and SCOS patients (Han et al., 2009) , which may reduce estrogen receptor binding and indirectly increase seminal estradiol levels; 2) seminal estradiol may concentrate in prostates, resulting in an increased seminal estradiol level. This finding is supported by previous work by (Risbridger et al., 2003) .
Estrogen and androgen can be considered two sides of the same coin. On one hand, androgens can be converted into estrogens; on the other, Sertoli cells are known to secrete fluid under androgen control, while estrogen is involved in the resorption of the fluid in the efferent ducts (Hess, 1997; Sharpe, 1997) .
Despite a lack of knowledge about the specific mechanisms of how estrogen, androgen, or their balance, affects spermatogenesis, this data clearly indicates that their local balance plays an important role in maintaining physiological spermatogenesis. Our results also suggest that seminal T/E 2 ratios in OA patients, especially those diagnosed with CAVD, may be a good indicator for predicting azoospermia.
Although some studies have claimed that serum testosterone levels demonstrate no relationship to sperm concentration or testicular biopsy (Jackaman et al., 1977; Goulis et al., 2008) , others suggest that testosterone may assume a critical role in both the morphological development and reproductive function in the male (Holdcraft, Braun, 2004; Takada et al., 2008) . Treatment with exogenous testosterone has been shown to fully rescue spermatogenesis in LH-R knockout mice (Lei et al., 2001) . In this study, NOA patients without sperm (-) show very low levels of seminal testosterone, as compared to NOA with sperm (+) patients; their biopsy tissues indicate severe seminiferous tubule atrophy, sclerosis and Leydig cell hyperplasia. These findings imply that seminal testosterone levels may predict whether normal spermatogenesis is occurring within the seminiferous tubules of NOA patients.
In addition, serum hormone levels (PRL, LH, FSH, E 2 and testosterone) were analyzed from NOA patients; the results suggest that FSH levels are significantly different between groups with sperm (+) and without sperm (-) (17.2±15.7 IU/L vs 29.2±18.3 IU/L, repectively). However, testosterone levels were not significantly deferent between the two groups (16.42±8.69 nmol/L vs. 12.98±5.79nmol/L, respectively) (unpublished data). Therefore FSH levels in serum may be considered as another indicator to predict normal sprmatogenesis in NOA patients ( Goulis et al., 2008) .
In summary, these results demonstrated that: 1) reduced T/E 2 ratios and increased seminal estradiol levels may reflect the type of obstruction or CAVD; 2) T/E 2 ratios coupled with seminal testosterone levels may serve as good indicators for predicting the success of surgically retrieving spermatozoa from the testes from non-obstructive azoospermic patients. However, additional research encompassing a larger patient population is needed to confirm these predictive values in helping to avoid unnecessary testicular biopsies. 
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